Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. (OMAB)

Theseus Pharmaceuticals Income Statement

Financials in millions MXN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	15,740	15,073	14,457	11,935	8,720	5,367
Revenue Growth (YoY)	5.85%	4.26%	21.13%	36.87%	62.46%	-37.05%
Cost of Revenue	4,157	4,240	4,305	4,045	3,084	2,412
Gross Profit	11,583	10,833	10,152	7,890	5,636	2,955
Selling, General & Admin	1,068	1,012	899.34	845.27	720.1	599.22
Other Operating Expenses	989.17	980.73	544.13	428.68	318.63	199.07
Operating Expenses	2,814	2,750	2,085	1,825	1,526	1,234
Operating Income	8,769	8,083	8,067	6,064	4,110	1,721
Interest Expense	-1,511	-1,329	-1,269	-934.1	-516.68	-420.5
Interest & Investment Income	171.69	245.07	297.91	171.31	129.48	111.89
Currency Exchange Gain (Loss)	14.46	69.88	-35.51	-8.87	112.62	79.52
EBT Excluding Unusual Items	7,444	7,069	7,060	5,293	3,836	1,492
Pretax Income	7,444	7,069	7,060	5,293	3,836	1,492
Income Tax Expense	2,247	2,133	2,039	1,376	972.18	394.5
Earnings From Continuing Operations	5,198	4,936	5,020	3,917	2,864	1,098
Minority Interest in Earnings	-12.87	-7.42	-8.58	-16.34	-6.37	-3.52
Net Income	5,185	4,929	5,012	3,901	2,857	1,094
Net Income to Common	5,185	4,929	5,012	3,901	2,857	1,094
Net Income Growth	3.17%	-1.66%	28.48%	36.53%	161.09%	-66.01%
Shares Outstanding (Basic)	386	386	386	386	389	390
Shares Outstanding (Diluted)	386	386	386	386	389	390
Shares Change (YoY)	-0.02%	-	-	-0.63%	-0.43%	-0.62%
EPS (Basic)	13.42	12.76	12.98	10.10	7.35	2.80
EPS (Diluted)	13.42	12.76	12.98	10.10	7.35	2.80
EPS Growth	3.19%	-1.66%	28.48%	37.40%	162.22%	-65.80%
Free Cash Flow	7,146	5,875	5,931	4,749	4,346	1,145
Free Cash Flow Per Share	18.50	15.21	15.36	12.30	11.18	2.94
Dividend Per Share	-	-	10.890	5.896	5.896	5.127
Dividend Growth	-	-	84.71%	-	15.00%	-
Gross Margin	73.59%	71.87%	70.22%	66.11%	64.64%	55.06%
Operating Margin	55.71%	53.63%	55.80%	50.81%	47.14%	32.07%
Profit Margin	32.94%	32.70%	34.67%	32.69%	32.77%	20.39%
Free Cash Flow Margin	45.40%	38.98%	41.02%	39.79%	49.83%	21.34%
EBITDA	9,545	8,799	8,667	6,572	4,556	2,157
EBITDA Margin	60.64%	58.37%	59.95%	55.06%	52.25%	40.18%
D&A For EBITDA	775.59	715.39	600.24	507.15	445.96	435.34
EBIT	8,769	8,083	8,067	6,064	4,110	1,721
EBIT Margin	55.71%	53.63%	55.80%	50.81%	47.14%	32.07%
Effective Tax Rate	30.18%	30.17%	28.89%	25.99%	25.35%	26.43%
Revenue as Reported	15,073	15,073	14,457	11,935	8,720	5,367

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q